Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance

International Journal of Infectious Diseases

Volumn 12, Issue 3, 2008, Pages 256-264

  Shahid, M ^a   Malik, A ^a   Akram, M ^b   Agrawal, L M ^a   Khan, A U ^b   Agrawal, M ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Cefoxitin resistance; Escherichia coli; Klebsiella pneumoniae; Modified three dimensional test; Resistance phenotypes; Spot inoculation method

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; AZTREONAM; BETA LACTAMASE AMPC; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIMENTIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NONHUMAN; TERTIARY HEALTH CARE;

ACADEMIC MEDICAL CENTERS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFOXITIN; CEPHALOSPORIN RESISTANCE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INDIA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PREVALENCE;

EID: 42149102220     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2007.08.008     Document Type: Article

References (29)

1. Beg A.Z., and Ahmad I. Effect of Plumbago zeylanica and certain curing agents on multidrug resistant bacteria of clinical origin. World J Microbiol Biotechnol 16 (2000) 841-844
2. Robin E.H., Anril W.M., Loeto M., and Keith K. Nasopharyngeal carriage and antimicrobial resistance in isolates of Streptococcus pneumoniae and Haemophilus influenzae type b in children under 5 years of age in Botswana. Int J Infect Dis 3 (1998) 18-25
3. Eichkoff T.C. Antibiotics and nosocomial infections. In: Bennett J.V., and Brachman P.S. (Eds). Hospital infections. 4th ed. (1998), Lippincott-Raven 201-213
4. Alvarez M., Tran J.H., Chow N., and Jacoby G.A. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 48 (2004) 533-537
5. Bauernfeind A., Chong Y., and Lee K. Plasmid encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?. Yonsei Med J 39 (1998) 520-525
6. Shahid M., Malik A., and Sheeba. Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC β-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India. FEMS Microbiol Lett 228 (2003) 181-186
7. Bauer A.W., Kirby W.M., Sherris J.C., and Turck M. Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol 45 (1966) 493-496
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests; approved standard M2-A7. 7th ed. (2000), National Committee for Clinical Laboratory Standards, Wayne, PA, USA
9. Livermore D.M., Winstanley T.G., and Shannon K.P. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother 48 Suppl 1 (2001) 87-102
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; ninth informational supplement (M100-S9) (1999), National Committee for Clinical Laboratory Standards, Wayne, PA, USA
11. Shahid M., Malik A., Agrawal M., and Singhal S. Phenotypic detection of extended-spectrum and AmpC β-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with conventional three-dimensional extract test. J Antimicrob Chemother 54 (2004) 684-687
12. Davis L.G., Dibner M.D., and Battey J.F. Large scale alkaline lysis method of plasmid purification. Basic methods in molecular biology (1986), Elsevier, New York p. 99
13. Shahid M., and Malik A. Plasmid mediated amikacin resistance in clinical isolates of Pseudomonas aeruginosa. Indian J Med Microbiol 22 (2004) 183-185
14. Portnoy D.A., Moseley S.L., and Falkow S. Characterization of plasmids and plasmid associated determinants of Yersinia enterocolitica pathogenesis. Infect Immunol 31 (1981) 775-782
15. Guerry P., and Colwell R.R. Isolation of cryptic plasmid deoxyribonucleic acid from Kanagawa positive strains of Vibrio parahaemolyticus. Infect Immunol 16 (1977) 28
16. Shahid M., and Malik A. MDR Pseudomonas aeruginosa in burn wounds: plasmid mediated resistance. Bionotes (2003) 6-7
17. Abigail S., Mathai E., Jesudason M.V., and John T.J. Ceftazidime resistance among Klebsiella pneumoniae in South India. Indian J Med Res 102 (1995) 53-55
18. Vogel L., Jones G., Triep S., Koek A., and Dijkshoorn L. RAPD typing of Klebsiella pneumoniae, Klebsiella oxytoca, Serratia marcescens and Pseudomonas aeruginosa isolates using standardized reagents. Clin Microbiol Infect 5 (1999) 270-276
19. Jarlier V., Nicolas M.H., Fournier G., and Phillipon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10 (1988) 867-878
20. Ananthakrishnan A.N., Kanungo R., Kumar A., and Badrinath S. Detection of extended-spectrum beta lactamase producers among surgical wound infections and burns patients in JIPMER. Indian J Med Microbiol 18 (2000) 160-165
21. Rao P.S., and Shivananda P.G. Bacteraemia due to non-fermenting Gram-negative bacilli in immunocompromised patients. Indian J Med Microbiol 11 (1993) 95-99
22. Veenu, Sikka R., and Arora D.R. Isolation and susceptibility pattern of non-fermenting Gram-negative bacilli from clinical samples. Indian J Med Microbiol 17 (1998) 14-18
23. Ghatole M., Manthalkar P., Kandle S., Yemul V., and Jahagirdar V. Correlation of extended-spectrum beta lactamases production with cephalosporin resistance in Gram-negative bacilli. Indian J Pathol Microbiol 47 (2004) 82-84
24. Navon-Venezia S., Hammer Munz O., Schwartz D., Turner D., Kuzmenko B., and Carmeli Y. Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. J Clin Microbiol 41 (2003) 155-158
25. Winokur P.L., Canton R., Casellas J.M., and Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32 Suppl 2 (2001) S94-S103
26. Coudron P.E., Moland E.S., and Thomson K.S. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 38 (2000) 1791-1796
27. Coudron P.E., Hanson N.D., and Climo M.W. Occurrence of extended-spectrum and AmpC β-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC β-lactamases. J Clin Microbiol 41 (2003) 772-777
28. Manchanda V., and Singh N.P. Occurrence and detection of AmpC β-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 51 (2003) 415-418
29. Gazouli M., Tzouvelekis L.S., Prinarakis E., Miriagou V., and Tzelepi E. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of plasmid-mediated group 1 β-lactamase (LAT-2). Antimicrob Agents Chemother 40 (1996) 1736-1740